Diffuse Large B-Cell Lymphoma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Meets the pathological diagnostic criteria for DLBCL; 2. Patients receiving initial treatment; 3. Age = 18 years; 4.TCM disease differentiation consistent with malignant nucleus, and syndrome differentiation consistent with phlegm-stasis intermingling syndrome; 5. Complete medical history documentation; 6. Signed informed consent, agrees to follow-up.
Exclusion criteria
Exclusion criteria: 1. Age < 18 years; 2. Coexisting severe underlying diseases or mental disorders; 3. Coexisting other malignant tumors; 4. Significant missing clinical data, relevant test results, or follow-up information.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy Evaluation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety Evaluation; | — |
Countries
China
Contacts
Shanghai Municipal Hospital of Traditional Chinese Medicine